An Observational, Prospective, Open label study comparing enteric-coated mycophenolate sodium (EC-MPS) with Mycophenolate mofetil (MMF) with calcineurin inhibitor (CNI) de-novo in patients after primary liver transplant.

Trial Profile

An Observational, Prospective, Open label study comparing enteric-coated mycophenolate sodium (EC-MPS) with Mycophenolate mofetil (MMF) with calcineurin inhibitor (CNI) de-novo in patients after primary liver transplant.

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 31 Aug 2016

At a glance

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top